1 Doses of clonidine 0.15 mg or guanfacine 1.0 mg, respectively, and 2 h later additional doses of clonidine 0.3 mg or guanfacine 2.0 mg, respectively, were given to 24 healthy students. 2 Blood pressure was reduced by the same amount by both drugs. 3 Plasma noradrenaline concentrations decreased with both drugs, but the reduction was significantly greater following the administration of clonidine. 4 Mental activity in the EEG was less suppressed in the guanfacine group than in the clonidine group. The differences were statistically significant. 5 Self-estimations for well-being and mood showed only small changes due to guanfacine but significant changes due to clonidine. 6 The decrease of information processing and the increase in reaction time, measured by performance in different psychometric tests, were significantly more pronounced after clonidine treatment than guanfacine. 7 A dose-response relationship could only be observed in vigilosomnograms, in the tests of selfestimation related to well-being and mood and in the decrease in plasma noradrenaline in the clonidine group. 8 It was concluded that guanfacine had a lesser CNS depressant action than clonidine, when administered in equipotent hypotensive doses.

A prospective study over 15 months in 100 elderly patients with signs of cerebro-vascular impairment demonstrated by psychometric testing that Hydergine (an ergot alkaloid preparation: 4.5 mg daily) compensated the signs of dementia, present in the placebo group, and in some patients actually brought about a significant improvement in mental activity. Similar compensatory effect was also demonstrable in cerebral haemodynamics: in the placebo group there was a progressive increase in cerebral circulation time, an expression of decreased cerebral blood flow, while with Hydergine cerebral circulation time was shortened and stabilized. Serial EEGs, obtained in parallel with psychometric and circulation time tests, demonstrated a marked increase in the 8-10 Hz pattern which corresponds to the physiological alpha activity in this age group. Furthermore, there was a diminished variability in performance in the tested frequency bands with Hydergine, the opposite tendency being obtained in the placebo group.

An Stoffwechselgesunden, vorwiegend jugendlichen Patienten, die wegen psychischer Störungen oder endogener Psychosen in unserer stationären Beobachtung standen, wurden Untersuchungen mit Rastinon unter Glukosebelastungen mit wechselnden Mengen durchgeführt. Die Belastung wurde, wie früher beschrieben (287a), über 8 Stunden ausgedehnt und es wurden in einer Doppelbelastung mit schlückchenweisem Trinken in 10 Min. Abstand 5 Stunden lang von 6-11 Uhr x g p. Std. und 3 Stunden lang von 11-14 Uhr 2 x g p.Std. gelöste Glukose verabfolgt. Rastinon wurde am Vortage um 18 Uhr, also 12 Stunden vor Versuchsbeginn gegeben. Während der gesamten Versuchsdauer von 11 Stunden erfolgten Blutzuckerentnahmen in stündlichen Abständen zu Doppelbestimmungen. Die Untersuchungen wurden jeweils mit 1, 2 und 3 g Rastinon angestellt. Als Belastungsmodus wurden neben dem Leerversuch die Belastungen x=5 g, (5/10), x=lO g (10/20), x=20 g (20/40), bzw. x=40 g (40/80) durchgeführt. Bei dem Belastungsmodus 5/10 wurden somit in 8 Stunden 55 g Glukose, bei 10/20 110 g, bei 20/40 220 g und bei 40/80 440 g Glukose gegeben. Die demonstrierten Mittel-

No abstract